MediPoint: Coronary Stents - Current and Future Players is a new market research publication announced by Reportstack. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.
The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation.
- Investigation of current and future market competition for Coronary Stents.
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice.
Reasons to buy
- Gain a high level view of the trends shaping and driving the Coronary Stents market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
Abbott Vascular Boston Scientific Corporation Medtronic Alvimedica Amaranth Medical amg International Arterial Remodeling Technologies B. Braun Balton Biosensors International Biotronik Blue Medical Cardionovum C.R. Bard Elixir Medical Corporation eucatech AG Hexacath IRAMED JW Medical Systems Kyoto Medical Planning Lepu Medical Technology MicroPort Scientific Corporation Minvasys MIV Therapeutics Opto Circuits OrbusNeich Medical Relisys Medical Devices REVA Medical Sahajanand Medical Technologies STENTYS Terumo Corporation Translumina Vascular Concepts Other Companies
Complete report available @ MediPoint: Coronary Stents - Current and Future Players.